文献速递肝病消化道肿瘤与早癌

基于分子特征鉴定肝细胞癌的免疫特异性类别

Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
PubMed 文献 · Gastroenterology · 2017-06-15

研究分析956例肝细胞癌样本,用非负矩阵分解算法分离肿瘤、间质和免疫细胞的基因表达谱,在228例训练集和728例验证集中验证,发现约25%肝细胞癌具有炎症反应标志物,称为免疫类,含适应性T细胞应答和耗竭免疫应答两个亚型。

要点

  • 约25%肝细胞癌表达炎症反应标志物,高表达CD274分子(程序性死亡配体1)和程序性死亡1。
  • 免疫类含两个亚型:适应性T细胞应答亚型和耗竭免疫应答亚型。
  • 耗竭免疫应答亚型表达转化生长因子β1调控的免疫抑制基因。

核心结论

  • 在956例肝细胞癌样本分析中,约25%表达炎症反应标志物,鉴定出适应性或耗竭免疫应答两个亚类,提示部分肝细胞癌可能对阻断T细胞调节通路的治疗药物敏感。

研究设计与样本

  • 分析956例肝细胞癌患者样本,用非负矩阵分解算法分离肿瘤、间质和免疫细胞的基因表达谱。
  • 在228例肝细胞癌训练集中将表达模式与免疫细胞浸润和免疫调节分子相关联,并在728例肿瘤样本验证集中验证。
  • 利用癌症基因组图谱中190例肿瘤数据,将免疫细胞基因表达谱与基于单核苷酸多态性阵列的染色体畸变数和基于外显子测序数据的突变相关联。

主要发现

  • 约25%肝细胞癌具有炎症反应标志物,高表达CD274分子(程序性死亡配体1)和程序性死亡1、细胞溶解活性标志物,且染色体畸变较少。
  • 该组肿瘤称为免疫类,含两个亚型,分别以适应性T细胞应答标志物或耗竭免疫应答为特征。
  • 耗竭免疫应答亚类表达许多由转化生长因子β1调控的介导免疫抑制的基因。
  • 免疫特异性类别与其他肝细胞癌在突变数量或肿瘤抗原表达上未观察到差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Agents that induce an immune response against tumors by altering T-cell regulation have increased survival times of patients with advanced-stage tumors, such as melanoma or lung cancer. We aimed to characterize molecular features of immune cells that infiltrate hepatocellular carcinomas (HCCs) to determine whether these types of agents might be effective against liver tumors. METHODS: We analyzed HCC samples from 956 patients. We separated gene expression profiles from tumor, stromal, and immune cells using a non-negative matrix factorization algorithm. We then analyzed the gene expression pattern of inflammatory cells in HCC tumor samples. We correlated expression patterns with the presence of immune cell infiltrates and immune regulatory molecules, determined by pathology and immunohistochemical analyses, in a training set of 228 HCC samples. We validated the correlation in a validation set of 728 tumor samples. Using data from 190 tumors in the Cancer Genome Atlas, we correlated immune cell gene expression profiles with numbers of chromosomal aberrations (based on single-nucleotide polymorphism array) and mutations (exome sequence data). RESULTS: We found approximately 25% of HCCs to have markers of an inflammatory response, with high expression levels of the CD274 molecule (programmed death-ligand 1) and programmed cell death 1, markers of cytolytic activity, and fewer chromosomal aberrations. We called this group of tumors the Immune class. It contained 2 subtypes, characterized by markers of an adaptive T-cell response or exhausted immune response. The exhausted immune response subclass expressed many genes regulated by transforming growth factor beta 1 that mediate immunosuppression. We did not observe any differences in numbers of mutations or expression of tumor antigens between the immune-specific class and other HCCs. CONCLUSIONS: In an analysis of HCC samples from 956 patients, we found almost 25% to express markers of an inflammatory response. We identified 2 subclasses, characterized by adaptive or exhausted immune responses. These findings indicate that some HCCs might be susceptible to therapeutic agents designed to block the regulatory pathways in T cells, such as programmed death-ligand 1, programmed cell death 1, or transforming growth factor beta 1 inhibitors.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Sia D, Jiao Y, Martinez-Quetglas I, et al. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology. 2017. PMID: 28624577. doi:10.1053/j.gastro.2017.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。